608sek
-4,3 %
Date:2025-08-01Time:18:00:00Latest report:Q1-2025List:First NorthTicker:ELIC
Market Cap:295 msekEnterprise Value:249 msekNet Sales:- msekEarnings:-18,8 msekEmployees:0ISIN:SE0015382080

Ratios

10-year key figure history for Elicera Therapeutics turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Elicera Therapeutics with index and moving average MA50 and MA200.

Stockprice:6,08
MA50:5,79
MA200:3,36
Price/MA200:80,9 %
RSI (14):58,4
Price/MA50:5,0 %

Description

Elicera Therapeutics operates in the pharmaceutical industry. The company specializes in research and development in immuno-oncology for cell and gene therapies for immune-based cancer treatment. In addition to its core business, it also offers related ancillary services. The business is conducted with the largest presence in Sweden. Elicera Therapeutics has its headquarters in Gothenburg.

Pharmaceuticals